Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada

Femasys Inc. has received approval from Health Canada for its FemCath intrauterine catheter, which is the first device to allow selective evaluation of fallopian tubes with contrast in the country. The product works together with Femasys' FemVue ultrasound-based diagnostic test as part of an infertility assessment before any therapeutic options can be considered, such as artificial insemination ..